Studies Point to Several Options for Ulcerative Colitis After Anti-TNF Failure

(MedPage Today) -- SAN FRANCISCO -- Research presented at the annual Crohn's and Colitis Congress included studies comparing the effectiveness of vedolizumab (Entyvio) versus ustekinumab (Stelara) and of each biologic against Janus kinase (JAK...